| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0005 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.001 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.001 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.74 | 0.004 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.004 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.09 | 0.005 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.006 |